Alzamend Other Wednesday, November 18, 2026 +0.20 Positive

Study Tracks Functional Brain Connectivity in Healthy Volunteers

Alzamend Neuro presented a study using ultra-high-field fMRI to compare the brain functional connectivity effects of its AL001 trial drug and lithium carbonate, finding similar connectivity patterns at the network level. This data supports the clinical development of the novel ionic lithium salicylate salt designed for reduced systemic toxicity compared to inorganic lithium salts.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed